BOPA Standards for Reducing Risks Associated with ePMA for SACT published

3 June 2019

The British Oncology Pharmacy Association recently published the BOPA Standards for Reducing Risks Associated with Electronic Prescribing and Medicines Administration Systems (ePMA) for Systemic Anti-Cancer Therapies (SACT). The document outlines steps that can be considered to be best practice in reducing the risks of errors arising from the introduction and use of e-prescribing systems for SACT within organisations. You may access the document via the SACT MIG Resources or click here.

If you have any queries please direct them to netty.cracknell@ramsayhealth.co.uk

UKONS

The UK Oncology Nursing Society
Registered Address: First Floor, 10 Queen Street Place, London EC4R 1BE
Charity Commission Number: 1136972
Companies House Registration Number: 6996552
VAT Registration Number: 290 7685 64

UKONS does not own all the documents on our website and shares them for member interest. We are not responsible for the use or recommendations of these documents, and members should use them at their discretion. UKONS cannot accept liability for errors, omissions, or consequences from applying the information and makes no warranties regarding the content. Documents are for healthcare professionals only; seek professional advice before acting on any content from our site or downloaded documents.